Quick and Effective Management of Diabetic Ketoacidosis (DKA)
For effective DKA management, administer continuous intravenous regular insulin at 0.1 units/kg/hour after initial assessment, provide aggressive fluid resuscitation with isotonic saline, and monitor electrolytes with particular attention to potassium replacement. 1
Initial Assessment and Diagnosis
Diagnostic criteria for DKA: 1
- Blood glucose >250 mg/dL
- Venous pH <7.3
- Bicarbonate <15 mEq/L
- Moderate ketonemia or ketonuria
Immediate laboratory tests (STAT): 1
- Blood glucose
- Venous blood gases (arterial gases usually unnecessary)
- Electrolytes
- BUN, creatinine
- Calcium, phosphorous
- Urinalysis
Treatment Algorithm
1. Fluid Replacement
- First 1-2 hours: 1-2 L of 0.9% normal saline at 15-20 mL/kg/hr 1
- Subsequent fluids: 0.45% saline at 4-14 mL/kg/hr once intravascular volume is restored 1
- Add glucose: When blood glucose falls to 200-250 mg/dL, switch to 5% dextrose with 0.45% saline 1
2. Insulin Therapy
- Standard approach: Continuous IV regular insulin at 0.1 units/kg/hour 1
- No initial bolus needed in pediatric patients
- For adults, some protocols include initial bolus of 0.1 units/kg
- Mild DKA alternative: For mild cases only, can use subcutaneous/IM insulin with initial "priming" dose of 0.4-0.6 units/kg (half IV bolus, half SC/IM) followed by 0.1 unit SC/IM hourly 1
- Rate adjustment: If glucose doesn't fall by 50-75 mg/dL in first hour, double insulin rate hourly until steady decline achieved 1
- Continue insulin: Even after blood glucose normalizes, continue insulin until acidosis resolves 1
3. Potassium Replacement
- Start replacement when: Serum K+ <5.3 mEq/L and adequate urine output confirmed 1
- Composition: 1/3 KPO₄ and 2/3 KCl or K-acetate 1
- Rate: Add 20-30 mEq potassium per liter of IV fluid 1
- Monitor: Check potassium every 2-3 hours during initial treatment 1
4. Bicarbonate Therapy
- Generally not recommended for pH >7.0 1
- Consider only if: pH <6.9, then administer 50 mmol sodium bicarbonate in 200 mL sterile water over 1 hour 1
Monitoring During Treatment
- Blood glucose: Every 1-2 hours 1
- Electrolytes, BUN, creatinine: Every 2-4 hours 1
- Venous pH and anion gap: Every 4-6 hours until resolution 1
- β-hydroxybutyrate (β-OHB): Preferred method for monitoring ketosis (if available) 1
- Avoid relying on urine ketones: Nitroprusside method doesn't measure β-OHB 1
Resolution Criteria and Transition to Subcutaneous Insulin
DKA resolution defined as: 1
- Glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
Transition to subcutaneous insulin: 1
- Start subcutaneous basal insulin 2-4 hours before stopping IV insulin
- Continue IV insulin for 1-2 hours after starting subcutaneous insulin
- Abrupt discontinuation without overlap can lead to recurrent DKA
Common Pitfalls to Avoid
- Inadequate fluid resuscitation: Underestimating fluid deficit leads to prolonged acidosis 1
- Premature discontinuation of insulin: Continue insulin until acidosis resolves, even if glucose normalizes 1
- Relying on urine ketones for monitoring: Use blood β-OHB when available 1
- Failure to identify and treat precipitating causes: Always look for infection, myocardial infarction, or stroke 1
- Inappropriate bicarbonate use: Generally not beneficial and may worsen hypokalemia 1
- Abrupt transition from IV to subcutaneous insulin: Ensure proper overlap to prevent rebound hyperglycemia 1
- Inadequate potassium replacement: Monitor closely as insulin therapy drives potassium intracellularly 1
By following this structured approach to DKA management, you can effectively treat this potentially life-threatening condition while minimizing complications and improving patient outcomes.